These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 4045195)

  • 21. Specificity of membrane complement receptor type three (CR3) for beta-glucans.
    Ross GD; Cain JA; Myones BL; Newman SL; Lachmann PJ
    Complement; 1987; 4(2):61-74. PubMed ID: 3040332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of beta-glucans binding to human/mouse dectin-1 and associated immunomodulatory effects on two monocyte/macrophage cell lines.
    Wu ML; Huang TC; Hung HJ; Yu JH; Chung WB; Chaung HC
    Biotechnol Prog; 2010; 26(5):1391-9. PubMed ID: 20945493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes.
    Elstad MR; Parker CJ; Cowley FS; Wilcox LA; McIntyre TM; Prescott SM; Zimmerman GA
    J Immunol; 1994 Jan; 152(1):220-30. PubMed ID: 7902855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The C3 activating capacity in human serum--measured as monocyte mediated chemiluminescence].
    Ernst M; Ennen J; Flad HD
    Immun Infekt; 1984 Feb; 12(1):35-6. PubMed ID: 6241919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.
    Agarwal S; Specht CA; Haibin H; Ostroff GR; Ram S; Rice PA; Levitz SM
    mBio; 2011; 2(5):. PubMed ID: 21878570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laminarin, a soluble beta-glucan, inhibits macrophage phagocytosis of zymosan but has no effect on lipopolysaccharide mediated augmentation of phagocytosis.
    Fuentes AL; Millis L; Sigola LB
    Int Immunopharmacol; 2011 Nov; 11(11):1939-45. PubMed ID: 21856445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.
    Boxx GM; Kozel TR; Nishiya CT; Zhang MX
    Infect Immun; 2010 Mar; 78(3):1250-9. PubMed ID: 20028806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
    Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD
    J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of yeast cell wall glucan by Atlantic salmon (Salmo salar L.) macrophages.
    Engstad RE; Robertsen B
    Dev Comp Immunol; 1993; 17(4):319-30. PubMed ID: 8375567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.
    Hamuro J; Hadding U; Bitter-Suermann D
    Immunology; 1978 Apr; 34(4):695-705. PubMed ID: 721136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening biomaterials for functional complement activation in serum.
    Lyle DB; Bushar GS; Langone JJ
    J Biomed Mater Res A; 2010 Jan; 92(1):205-13. PubMed ID: 19172622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines.
    Müller A; Rice PJ; Ensley HE; Coogan PS; Kalbfleish JH; Kelley JL; Love EJ; Portera CA; Ha T; Browder IW; Williams DL
    J Immunol; 1996 May; 156(9):3418-25. PubMed ID: 8617968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracts of wheat gluten activate complement via the alternative pathway.
    Unsworth DJ; Würzner R; Brown DL; Lachmann PJ
    Clin Exp Immunol; 1993 Dec; 94(3):539-43. PubMed ID: 8252813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phagocytosis by human monocytes of unopsonized particulate activators of the human alternative complement pathway: induction by cytokine.
    Chakravarti B; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1986 Aug; 137(3):880-6. PubMed ID: 3088115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide-mediated enhancement of zymosan phagocytosis by RAW 264.7 macrophages is independent of opsonins, laminarin, mannan, and complement receptor 3.
    Fuentes AL; Millis L; Vapenik J; Sigola L
    J Surg Res; 2014 Jun; 189(2):304-12. PubMed ID: 24726062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
    Johnson E; Eskeland T; Bertheussen K
    Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A beta-glucan inhibitable zymosan receptor on channel catfish neutrophils.
    Ainsworth AJ
    Vet Immunol Immunopathol; 1994 May; 41(1-2):141-52. PubMed ID: 8066990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonopsonic uptake of Mycobacterium avium complex by human monocytes and alveolar macrophages.
    Roecklein JA; Swartz RP; Yeager H
    J Lab Clin Med; 1992 Jun; 119(6):772-81. PubMed ID: 1593222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
    Pham Huu T; Buriot D; Griscelli C
    Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.